Icon

ZOLADEX (nda019726)- (EQ 3.6MG BASE)

GOSERELIN ACETATE TERSERA
EQ 3.6MG BASE
No No
2022-Apr-13 Expired
None None
None No
ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for:  Use in combination with flutamide for the management of locally confined carcinoma of the prostate  Palliative treatment of advanced carcinoma of the prostate  The management of endometriosis  Use as an endometrial-thinning agent prior to endometrial ablation for dysfunctional uterine bleeding  Use in the palliative treatment of advanced breast cancer in pre- and perimenopausal women
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 3.6MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.